BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24628054)

  • 1. Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction.
    Nakai Y; Isayama H; Kawakubo K; Kogure H; Hamada T; Togawa O; Ito Y; Matsubara S; Arizumi T; Yagioka H; Takahara N; Uchino R; Mizuno S; Miyabayashi K; Yamamoto K; Sasaki T; Yamamoto N; Hirano K; Tada M; Koike K
    J Gastroenterol Hepatol; 2014; 29(7):1557-62. PubMed ID: 24628054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction.
    Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Yoshida M; Yamashita H; Umemura S; Hori Y; Ohara H; Joh T
    J Gastroenterol Hepatol; 2013 Jan; 28(1):68-72. PubMed ID: 23020651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction.
    Isayama H; Kawabe T; Nakai Y; Tsujino T; Sasahira N; Yamamoto N; Arizumi T; Togawa O; Matsubara S; Ito Y; Sasaki T; Hirano K; Toda N; Komatsu Y; Tada M; Yoshida H; Omata M
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1148-53. PubMed ID: 16904950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
    Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
    Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor invasion to the arteries feeding the gallbladder as a novel risk factor for cholecystitis after metallic stent placement in distal malignant biliary obstruction.
    Sogabe Y; Kodama Y; Honjo H; Aoyama I; Muramoto Y; Koga E; Yanaidani T; Kawai M; Yoshikawa T; Matsumoto S; Matsumoto A; Mori Y; Ono C; Nishida M; Nishida Y; Mikami T; Matsunaga Y; Miyamoto Y; Kitami M; Nishikawa K; Kondo M; Miyake N; Kawanami C; Seno H
    Dig Endosc; 2018 May; 30(3):380-387. PubMed ID: 29181859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer.
    Nakai Y; Isayama H; Kogure H; Hamada T; Togawa O; Ito Y; Matsubara S; Arizumi T; Yagioka H; Mizuno S; Sasaki T; Yamamoto N; Hirano K; Tada M; Koike K
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1744-9. PubMed ID: 24720610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events of self-expandable metal stent placement for malignant distal biliary obstruction: a large multicenter study.
    Tamura T; Yamai T; Uza N; Yamasaki T; Masuda A; Tomooka F; Maruyama H; Shigekawa M; Ogura T; Kuriyama K; Asada M; Matsumoto H; Takenaka M; Mandai K; Osaki Y; Matsumoto K; Sanuki T; Shiomi H; Yamagata Y; Doi T; Inatomi O; Nakanishi F; Emori T; Shimatani M; Asai S; Fujigaki S; Shimokawa T; Kitano M
    Gastrointest Endosc; 2024 Jan; 99(1):61-72.e8. PubMed ID: 37598864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and treatment strategies for cholecystitis after metallic stent placement for malignant biliary obstruction: a multicenter retrospective study.
    Matsumi A; Kato H; Ogawa T; Ueki T; Wato M; Fujii M; Toyokawa T; Harada R; Ishihara Y; Takatani M; Tsugeno H; Yunoki N; Tomoda T; Mitsuhashi T; Otsuka M
    Gastrointest Endosc; 2024 Jul; 100(1):76-84. PubMed ID: 38490459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation and comparison of cumulative incidences of biliary self-expandable metallic stent dysfunction accounting for competing risks.
    Hamada T; Nakai Y; Isayama H; Togawa O; Kogure H; Kawakubo K; Tsujino T; Sasahira N; Hirano K; Yamamoto N; Ito Y; Sasaki T; Mizuno S; Toda N; Tada M; Koike K
    Dig Endosc; 2014 Mar; 26(2):270-5. PubMed ID: 23650933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis.
    Almadi MA; Barkun AN; Martel M
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):27-37.e1. PubMed ID: 23103324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction.
    Suk KT; Kim HS; Kim JW; Baik SK; Kwon SO; Kim HG; Lee DH; Yoo BM; Kim JH; Moon YS; Lee DK
    Gastrointest Endosc; 2006 Oct; 64(4):522-9. PubMed ID: 16996343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial.
    Yang MJ; Kim JH; Yoo BM; Hwang JC; Yoo JH; Lee KS; Kang JK; Kim SS; Lim SG; Shin SJ; Cheong JY; Lee KM; Lee KJ; Cho SW
    Scand J Gastroenterol; 2015; 50(12):1490-9. PubMed ID: 26133200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cholecystitis after stent placement in patients with distal malignant biliary obstruction.
    Takinami M; Murohisa G; Yoshizawa Y; Shimizu E; Nagasawa M
    J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):470-476. PubMed ID: 32462813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of covered metallic stents with cholecystitis and stent migration in malignant biliary stricture.
    Jang S; Stevens T; Parsi M; Lopez R; Zuccaro G; Dumot J; Vargo JJ
    Gastrointest Endosc; 2018 Apr; 87(4):1061-1070. PubMed ID: 28867074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.
    Saleem A; Leggett CL; Murad MH; Baron TH
    Gastrointest Endosc; 2011 Aug; 74(2):321-327.e1-3. PubMed ID: 21683354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous cystic duct stent placement for the treatment of acute cholecystitis resulting from common bile duct stent placement for malignant obstruction.
    Sheiman RG; Stuart K
    J Vasc Interv Radiol; 2004 Sep; 15(9):999-1001. PubMed ID: 15361570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study.
    Isayama H; Mukai T; Itoi T; Maetani I; Nakai Y; Kawakami H; Yasuda I; Maguchi H; Ryozawa S; Hanada K; Hasebe O; Ito K; Kawamoto H; Mochizuki H; Igarashi Y; Irisawa A; Sasaki T; Togawa O; Hara T; Kamada H; Toda N; Kogure H
    Gastrointest Endosc; 2012 Jul; 76(1):84-92. PubMed ID: 22482918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture.
    Miura S; Kanno A; Masamune A; Hamada S; Hongou S; Yoshida N; Nakano E; Takikawa T; Kume K; Kikuta K; Hirota M; Yoshida H; Katayose Y; Unno M; Shimosegawa T
    Endoscopy; 2016 Jun; 48(6):536-45. PubMed ID: 26987646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Mechanical forces of Self-Expandable Metal Stents in the Biliary Ducts.
    Isayama H; Nakai Y; Hamada T; Matsubara S; Kogure H; Koike K
    Curr Gastroenterol Rep; 2016 Dec; 18(12):64. PubMed ID: 27778304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for the failure of endoscopic stent-in-stent self-expandable metallic stent placement to treat malignant hilar biliary obstruction.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Sato Y; Hikichi T; Ohira H
    World J Gastroenterol; 2017 Sep; 23(34):6273-6280. PubMed ID: 28974893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.